Decreasing Body Dissatisfaction in Male College Athletes: A Randomized Controlled Trial of the Male Athlete Body Project
Public ClinicalTrials.gov record NCT04077177. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Body Dissatisfaction (BD) is associated with marked distress and often precipitates disordered eating symptomology (Milligan \& Pritchard, 2006). BD in male athletes is an important area to explore, as research in this field often focuses on eating disorders in female athletes (e.g., Becker et al., 2012; Varnes et al., 2013). The current body of literature regarding male college athletes suggests that they experience pressures associated with both societal muscular ideals and sport performance (Galli et al., 2015). While there is a clear association between drive for muscularity and BD in collegiate male athletes (Galli et al., 2015), no study to date has conducted research aimed to attenuate the effect of BD in this population. The current study seeks to investigate a BD intervention for male college athletes. Participants will be randomized to an adapted version of the standardized Female Athlete Body Project (i.e., the Male Athlete Body Project) or an assessment only control condition. All participants will complete baseline and post-treatment measures of BD, negative affect, internalization of an athletic ideal, drive for muscularity, sport confidence, eating pathology, and unhealthy weight-control behaviors. Study aims are to determine if the Male Athlete Body Project intervention group reduces BD and related factors post-treatment, and to investigate whether these differences are maintained at 1-month follow up. Results will inform mental health and sport clinicians, coaches, and other personnel involved in an athlete's care about successful strategies for decreasing BD.
Study identification
- NCT ID
- NCT04077177
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 83 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 14, 2019
- Primary completion
- Mar 19, 2020
- Completion
- Mar 19, 2020
- Last update posted
- Sep 27, 2020
2019 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Illinois Institute of Technology | Chicago | Illinois | 606016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04077177, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2020 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04077177 live on ClinicalTrials.gov.